SCHEMBL6509125

SCHEMBL6509125

c1ccc2ncc(NC3CCNCC3)cc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MALT1 Q9UDY8 1/20 0.56
TRPV1 Q8NER1 1/20 0.53
ULK1 O75385 1/20 0.49
HTR6 P50406 5/20 0.46
HTR2B P41595 4/20 0.46
HTR1A P08908 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MET P08581 1/20 0.45
PDE3B Q13370 1/20 0.45
PDE3A Q14432 1/20 0.45
KDM4E B2RXH2 3/20 0.44
TP53 P04637 2/20 0.44
HSD17B10 Q99714 2/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAPT P10636 1/20 0.44
RECQL P46063 1/20 0.44
BLM P54132 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1872170 0.99 MALT1 (0.55) MALT1TRPV1ULK1HTR6HTR2B
Hydrochloric Acid SCHEMBL23359869 0.99 MALT1 (0.55) MALT1TRPV1ULK1HTR6HTR2B
Hydrochloric Acid SCHEMBL23360315 0.90 MALT1 (0.50) MALT1TRPV1ULK1HTR6NPSR1
Hydrochloric Acid SCHEMBL23359861 0.90 MALT1 (0.50) MALT1TRPV1ULK1HTR6NPSR1
Hydrochloric Acid SCHEMBL23359860 0.90 MALT1 (0.50) MALT1TRPV1ULK1HTR6NPSR1
Hydrochloric Acid SCHEMBL23360376 0.82 HTR6 (0.47) MALT1HTR6HTR2BHTR1AMET
Hydrochloric Acid SCHEMBL23360074 0.81 MET (0.48) MALT1HTR6HTR2BHTR1AMET
Hydrochloric Acid SCHEMBL23359865 0.79 PIM1 (0.43) MALT1HTR6HTR2BHTR1AHSD17B10
Hydrochloric Acid SCHEMBL29863142 0.79 PIM1 (0.43) MALT1HTR6HTR2BHTR1AHSD17B10
Hydrochloric Acid SCHEMBL23360217 0.78 HPGDS (0.62) HTR6CYP1A2IRAK4PDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7939661-B2 Antidiabetic agents; somatostatin receptor subtype 5 modulators; noninsulin dependent diabetes mellitus; side effect reduction; synthesis HOFFMAN-LA ROCHE INC. (US) 2011-05-10 US disclosed
US-7939661-B2 Antidiabetic agents; somatostatin receptor subtype 5 modulators; noninsulin dependent diabetes mellitus; side effect reduction; synthesis HOFFMAN-LA ROCHE INC. (US) 2011-05-10 US disclosed
WO-2008031735-A1 PYRIDINE- AND QUINOLINE-PYRIMIDINE-DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2008-03-20 WO disclosed
US-20080064697-A1 PYRIDINE, QUINOLINE AND PYRIMIDINE DERIVATIVES HOFFMAN-LA ROCHE INC. 2008-03-13 US disclosed
US-20080064697-A1 PYRIDINE, QUINOLINE AND PYRIMIDINE DERIVATIVES HOFFMAN-LA ROCHE INC. 2008-03-13 US disclosed
WO-2005019200-A2 ARYL PIPERIDINE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064697-A1 PYRIDINE, QUINOLINE AND PYRIMIDINE DERIVATIVES SSTR5, SSTR3, NPY5R MALT1 3604/4885TRPV1 580/4885ULK1 2189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.